Rosetta Genomics Ltd. Financing Cash Flow
Rosetta Genomics Ltd. reported Financing Cash Flow of $5.01 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2015-03-16
| Period end | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|
| 2014-12-31 | $5.01M 20-F · filed 2015-03-16 | |
| 2014-06-30 | $2.96M 6-K · filed 2014-09-17 | |
| 2013-12-31 | $4.74M 20-F · filed 2015-03-16 | |
| 2013-06-30 | $2.86M 6-K · filed 2014-09-17 | |
| 2012-12-31 | $38.92M 20-F · filed 2015-03-16 | |
| 2012-06-30 | $10.65M 6-K · filed 2013-09-09 | |
| 2011-12-31 | $11.80M 20-F · filed 2014-03-31 | |
| 2011-06-30 | $10.48M 6-K · filed 2012-09-28 | |
| 2010-12-31 | $6.98M 20-F · filed 2013-03-22 | |
| 2009-12-31 | $6.45M 6-K · filed 2012-12-07 |